CanSino Biologics Inc Tangible Net Worth Ratio
CanSino Biologics Inc tangible net worth ratio. CanSino Biologics Inc (CJH) has a Tangible Net Worth Ratio of 93.7% as of December 2025. This metric is calculated by deducting intangible assets (€313.69 Million) from net assets (€4.95 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check strategic asset allocation of CanSino Biologics Inc to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of CanSino Biologics Inc (2016–2025)
Tangible net worth ratio of CanSino Biologics Inc from 2016 to 2025. This chart shows how CanSino Biologics Inc's Tangible Net Worth Ratio has changed across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 93.7%, reflecting net assets of €4.95 Billion with intangible assets of €313.69 Million EUR. See CJH working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
CanSino Biologics Inc Tangible Net Worth Ratio by Year (2016–2025)
CanSino Biologics Inc tangible net worth ratio by year from 2016 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for CanSino Biologics Inc from 2016 to 2025, covering 10 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see how much is CanSino Biologics Inc worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 93.7% | €4.95 Billion | €313.69 Million | €7.18 Billion | ▼ -0.8 pp |
| 2024 | 94.5% | €4.91 Billion | €271.60 Million | €7.96 Billion | ▼ -1.6 pp |
| 2023 | 96.1% | €5.29 Billion | €205.65 Million | €9.32 Billion | ▼ -0.3 pp |
| 2022 | 96.4% | €7.25 Billion | €258.74 Million | €11.47 Billion | ▼ -1.3 pp |
| 2021 | 97.7% | €8.55 Billion | €198.31 Million | €11.87 Billion | ▼ -1.1 pp |
| 2020 | 98.8% | €6.07 Billion | €72.30 Million | €6.75 Billion | ▲ +2.7 pp |
| 2019 | 96.1% | €1.47 Billion | €57.22 Million | €1.78 Billion | ▲ +6.3 pp |
| 2018 | 89.8% | €502.32 Million | €51.26 Million | €795.88 Million | ▼ -3.5 pp |
| 2017 | 93.3% | €607.33 Million | €40.76 Million | €866.36 Million | ▲ +2.5 pp |
| 2016 | 90.8% | €214.47 Million | €19.76 Million | €326.17 Million | — |